JOURNAL BROWSE
Search
Advanced SearchSearch Tips
3D QSAR Study of 2-Methoxyphenylpiperazinylakanamides as 5-Hydroxytryptamine (Serotonin) Receptor 7 Antagonists
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of the Chosun Natural Science
  • Volume 9, Issue 2,  2016, pp.128-135
  • Publisher : The Research Institute of Chosun Natural Science
  • DOI : 10.13160/ricns.2016.9.2.128
 Title & Authors
3D QSAR Study of 2-Methoxyphenylpiperazinylakanamides as 5-Hydroxytryptamine (Serotonin) Receptor 7 Antagonists
Nagarajan, Santhosh Kumar; Madhavan, Thirumurthy;
  PDF(new window)
 Abstract
5-hydroxytryptamine (serotonin) receptor () 7 is one of G-Protein coupled receptors, which is activated by the neurotransmitter Serotonin. After activation by serotonin, activates the production of the intracellular signaling molecule cyclic AMP. receptor has been found to be involved in the pathophysiology of various disorders. It is reported that receptor antagonists can be used as antidepressant agents. In this study, we report the important structural and chemical parameters for 2-methoxyphenylpiperazinylakanamides as inhibitors. A 3D QSAR study based on comparative molecular field analysis (CoMFA) was performed. The best predictions were obtained for the best CoMFA model with of 0.594 with 6 components, of 0.986, Fisher value as 60.607, and an estimated standard error of 0.043. The predictive ability of the test set was 0.602. Results obtained the CoMFA models suggest that the data are well fitted and have high predictive ability. The contour maps are generated and studied. The contour analyses may serve as tool in the future for designing of novel and more potent derivatives.
 Keywords
3D-QSAR;CoMFA;;Serotonin;
 Language
English
 Cited by
 References
1.
P. Vanhoenacker, G. Haegeman, and J. E. Leysen, "5-HT7 receptors: current knowledge and future prospects", Trends Pharmacol. Sci., Vol. 21, pp. 70-77, 2000. crossref(new window)

2.
M. Ruat, E. Traiffort, R. Leurs, J. Tardivel-Lacombe, J. Diaz, J. M. Arrang, and J. C. Schwartz, "Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation", P. Natl. Acad. Sci. U.S.A., Vol. 90, pp. 8547-8551, 1993. crossref(new window)

3.
J. A. Bard, J. Zgombick, N. Adham, P. Vaysse, T. A. Branchek, and R. L. Weinshank, "Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase", J. Biol. Chem., Vol. 268, pp. 23422-23426, 1993.

4.
D. Hoyer, D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena, and P. P. Humphrey, "International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)", Pharmacol Rev., Vol. 46, pp. 157-203, 1994.

5.
J. P. P. Foong and J. C. Bornstein, "5-HT antagonists NAN-190 and SB 269970 block alpha2-adrenoceptors in the guinea pig", Neuroreport, Vol. 20, pp. 325-330, 2009. crossref(new window)

6.
G. Sarkisyan, A. J. Roberts, and P. B. Hedlund, "The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior", Behav. Brain Res., Vol. 209, pp. 99-108, 2010. crossref(new window)

7.
O. Mnie-Filali, C. Faure, L. Lambas-Senas, E. M. Mansari, H. Belblidia, E. Gondard, A. Etievant, H. Scarna, A. Didier, A. Berod, P. Blier, and N, Haddjeri, "Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy", Neuropsychopharmacol., Vol. 36, pp. 1275-1288, 2011. crossref(new window)

8.
G. S. Perez-García and A. Meneses, "Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task", Behav. Brain Res., Vol. 163, pp. 136-140, 2005. crossref(new window)

9.
V. S. Naumenko, N. K. Popova, E. Lacivita, M. Leopoldo, and E. G. Ponimaskin, "Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders". CNS Neurosci. Ther., Vol 20 pp. 582-590, 2014. crossref(new window)

10.
K. A. Krobert and F. O. Levy, "The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects", Brit. J. Pharmacol., Vol 135, pp. 1563-1571, 2002. crossref(new window)

11.
Y. Kim, J. Tae, K. Lee, H. Rhim, I. H. Choo, H. Cho, W.-K. Park, G. Keum, and H. Choo, "Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression", Bioorgan. Med. Chem., Vol. 22, pp. 4587-4596, 2014. crossref(new window)

12.
S. J. Cho and A. Tropsha, "Cross-validated R2-guided region selection for comparative molecular field analysis: A simple method to achieve consistent results", J. Med. Chem., Vol. 38, pp. 1060-1066, 1995. crossref(new window)

13.
S. Wold, M. Sjostrom, and L. Eriksson, "PLS-regression: a basic tool of chemometrics", Chemometr. intell. lab., Vol. 58, pp. 109-130, 2001. crossref(new window)

14.
U. Debnath, S. Verma, S. Jain, S. B. Katti, and Y. S. Prabhakar, "Pyridones as NNRTIs against HIV-1 mutants: 3D-QSAR and protein informatics" J. Comput. Aid. Mol. Des., Vol. 27, pp. 637-654, 2013. crossref(new window)

15.
D. Fernandez, J. Ortega-Castro, and J. Frau, "Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: A 3D-QSAR study" J. Comput. Aid. Mol. Des., Vol. 27, pp. 739-754, 2013. crossref(new window)